Palmitoyl oligopeptide

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name

DrugBank Accession Number

DB11297

Background

Not Available

Type

Small Molecule

Groups

Experimental

Structure

Similar Structures

Weight: Average: 578.799
Monoisotopic: 578.415568863
Chemical Formula: C₃₀H₅₄N₆O₅

Synonyms

Palmitoyl oligopeptide
Palmitoyl tripeptide-1

Poor quality drug data slowing you down?

Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.

Download eBook

Poor quality drug data slowing you down?

Download eBook

Pharmacology

Indication: Not Available
Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings: Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics: Not Available
Mechanism of action: Not Available
Absorption: Not Available
Volume of distribution: Not Available
Protein binding: Not Available
Metabolism: Not Available
Route of elimination: Not Available
Half-life: Not Available
Clearance: Not Available
Adverse Effects: Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity: Not Available
Pathways: Not Available
Pharmacogenomic Effects/ADRs: Not Available

Interactions

Drug Interactions: This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions: Not Available

Products

Drug product information from 10+ global regions

Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.

Access now

Access drug product information from over 10 global regions.

Access now

Mixture Products

Name	Ingredients	Dosage	Route	Labeller	Marketing Start	Marketing End
Buddate Reges Intensive Treatment	Palmitoyl oligopeptide (0.000006 g/100mL) + Butylene glycol (5.57 g/100mL) + Hydrogenated coconut oil (4 g/100mL) + Palmitoyl tetrapeptide-7 (0.000006 g/100mL) + Shea butter (3 g/100mL)	Cream	Topical	Buddate Co Ltd	2017-01-01	Not applicable
Buddate Reges Intensive Treatment	Palmitoyl oligopeptide (0.000006 g/100mL) + Butylene glycol (5.57 g/100mL) + Hydrogenated coconut oil (4 g/100mL) + Palmitoyl tetrapeptide-7 (0.000006 g/100mL) + Shea butter (3 g/100mL)	Cream	Topical	Buddate Co Ltd	2017-01-01	2017-01-02
Cosmeceutical Mask Pack	Palmitoyl oligopeptide (0.044 mg/22g) + Basic Fibroblast Growth Factor (0.044 mg/22g) + Mecasermin (0.044 mg/22g) + Nepidermin (0.044 mg/22g) + Prezatide copper (0.22 mg/22g) + Thioredoxin (0.044 mg/22g)	Patch	Topical	YBK Investment, INC	2013-10-21	2013-10-29
Cosmeceutical Mask Pack	Palmitoyl oligopeptide (0.044 mg/22g) + Basic Fibroblast Growth Factor (0.044 mg/22g) + Mecasermin (0.044 mg/22g) + Nepidermin (0.044 mg/22g) + Prezatide copper (0.22 mg/22g) + Thioredoxin (0.044 mg/22g)	Patch	Topical	YBK Investment, INC	2013-10-21	Not applicable
Derma Anti-Wrinkles	Palmitoyl oligopeptide (0.0009 mg/30g) + Hyaluronic acid (0.3 mg/30g) + Vitamin A palmitate (0.9 mg/30g)	Cream	Topical	Pella Pharmaceuticals Co. ltd	2014-12-24	Not applicable

Unapproved/Other Products

Name	Ingredients	Dosage	Route	Labeller	Marketing Start	Marketing End
Buddate Reges Intensive Treatment	Palmitoyl oligopeptide (0.000006 g/100mL) + Butylene glycol (5.57 g/100mL) + Hydrogenated coconut oil (4 g/100mL) + Palmitoyl tetrapeptide-7 (0.000006 g/100mL) + Shea butter (3 g/100mL)	Cream	Topical	Buddate Co Ltd	2017-01-01	Not applicable
Buddate Reges Intensive Treatment	Palmitoyl oligopeptide (0.000006 g/100mL) + Butylene glycol (5.57 g/100mL) + Hydrogenated coconut oil (4 g/100mL) + Palmitoyl tetrapeptide-7 (0.000006 g/100mL) + Shea butter (3 g/100mL)	Cream	Topical	Buddate Co Ltd	2017-01-01	2017-01-02
Cosmeceutical Mask Pack	Palmitoyl oligopeptide (0.044 mg/22g) + Basic Fibroblast Growth Factor (0.044 mg/22g) + Mecasermin (0.044 mg/22g) + Nepidermin (0.044 mg/22g) + Prezatide copper (0.22 mg/22g) + Thioredoxin (0.044 mg/22g)	Patch	Topical	YBK Investment, INC	2013-10-21	2013-10-29
Cosmeceutical Mask Pack	Palmitoyl oligopeptide (0.044 mg/22g) + Basic Fibroblast Growth Factor (0.044 mg/22g) + Mecasermin (0.044 mg/22g) + Nepidermin (0.044 mg/22g) + Prezatide copper (0.22 mg/22g) + Thioredoxin (0.044 mg/22g)	Patch	Topical	YBK Investment, INC	2013-10-21	Not applicable
Derma Anti-Wrinkles	Palmitoyl oligopeptide (0.0009 mg/30g) + Hyaluronic acid (0.3 mg/30g) + Vitamin A palmitate (0.9 mg/30g)	Cream	Topical	Pella Pharmaceuticals Co. ltd	2014-12-24	Not applicable

Chemical Identifiers

UNII: RV743D216M
CAS number: 147732-56-7
InChI Key: BYUQATUKPXLFLZ-UIOOFZCWSA-N
InChI: InChI=1S/C30H54N6O5/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-18-27(37)33-22-28(38)35-26(20-24-21-32-23-34-24)29(39)36-25(30(40)41)17-15-16-19-31/h21,23,25-26H,2-20,22,31H2,1H3,(H,32,34)(H,33,37)(H,35,38)(H,36,39)(H,40,41)/t25-,26-/m0/s1
IUPAC Name: (2S)-6-amino-2-[(2S)-2-(2-hexadecanamidoacetamido)-3-(1H-imidazol-4-yl)propanamido]hexanoic acid
SMILES: CCCCCCCCCCCCCCCC(=O)NCC(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CCCCN)C(O)=O

References

General References

Not Available

External Links

ChemSpider: 8407354
RxNav: 1722914
ZINC: ZINC000113569616

Clinical Trials

Clinical Trials

Phase	Status	Purpose	Conditions	Count

Pharmacoeconomics

Manufacturers

Not Available

Packagers

Not Available

Dosage Forms

Form	Route	Strength
Cream	Topical
Gel	Topical
Patch	Topical

Prices

Not Available

Patents

Not Available

Properties

State

Not Available

Experimental Properties

Not Available

Predicted Properties

Property	Value	Source
Water Solubility	0.00146 mg/mL	ALOGPS
logP	1.34	ALOGPS
logP	1.24	Chemaxon
logS	-5.6	ALOGPS
pKa (Strongest Acidic)	3.49	Chemaxon
pKa (Strongest Basic)	10.2	Chemaxon
Physiological Charge	0	Chemaxon
Hydrogen Acceptor Count	7	Chemaxon
Hydrogen Donor Count	6	Chemaxon
Polar Surface Area	179.3 Å²	Chemaxon
Rotatable Bond Count	26	Chemaxon
Refractivity	158.79 m³·mol^-1	Chemaxon
Polarizability	68.63 Å³	Chemaxon
Number of Rings	1	Chemaxon
Bioavailability	0	Chemaxon
Rule of Five	No	Chemaxon
Ghose Filter	No	Chemaxon
Veber's Rule	No	Chemaxon
MDDR-like Rule	No	Chemaxon

Predicted ADMET Features

Not Available

Spectra

Mass Spec (NIST)

Not Available

Spectra

Spectrum	Spectrum Type	Splash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)	Predicted LC-MS/MS	splash10-003r-2141390000-16090b246c07b304e42a
Predicted MS/MS Spectrum - 10V, Negative (Annotated)	Predicted LC-MS/MS	splash10-004i-0100090000-2a6f08670814413d58e7
Predicted MS/MS Spectrum - 20V, Negative (Annotated)	Predicted LC-MS/MS	splash10-055b-0494380000-c8db970467f114d0e489
Predicted MS/MS Spectrum - 20V, Positive (Annotated)	Predicted LC-MS/MS	splash10-08gi-5880970000-0610c2d0bfc650b37d41
Predicted MS/MS Spectrum - 40V, Negative (Annotated)	Predicted LC-MS/MS	splash10-000i-2519100000-04c9e1eaacea35644fa3
Predicted MS/MS Spectrum - 40V, Positive (Annotated)	Predicted LC-MS/MS	splash10-03di-3930300000-ab6c7013ba8bd84f948f

Chromatographic Properties

Collision Cross Sections (CCS)

Not Available

Drug created at December 03, 2015 16:52 / Updated at June 12, 2020 16:53

Palmitoyl oligopeptide

Identification

Structure for Palmitoyl oligopeptide (DB11297)

Pharmacology

Interactions

Products

Categories

Chemical Identifiers

References

Clinical Trials

Pharmacoeconomics

Properties

Spectra

Collision Cross Sections (CCS)